Yandan Liu
Overview
Explore the profile of Yandan Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen M, Zhou Q, Li Y, Lu Q, Bai A, Ruan F, et al.
BMC Med
. 2025 Jan;
23(1):7.
PMID: 39757174
Background: Maternal stress is a potential factor affecting fetal growth, but it is unknown whether it directly affects fetal growth restriction. This study aims to investigate the association between pre-pregnancy...
2.
Ren Z, Zhao W, Li D, Yu P, Mao L, Zhao Q, et al.
Circulation
. 2023 Dec;
149(14):1121-1138.
PMID: 38152931
Background: Progressive remodeling of cardiac gene expression underlies decline in cardiac function, eventually leading to heart failure. However, the major determinants of transcriptional network switching from normal to failed hearts...
3.
Duan G, Zhou R, Wang L, Zheng C, Liu Y, Chai X, et al.
J Environ Manage
. 2023 Oct;
348:119330.
PMID: 37871548
Many soil and water conservation measures (SWCM) have been implemented in the Loess Plateau of China, and they have an impact on ecosystems all levels and involve complicated mechanisms. Previously,...
4.
Yang D, Gong Z, Ye C, Huang H, Liu Y, Bai B
Am J Transl Res
. 2022 Nov;
14(10):7578-7584.
PMID: 36398262
Objective: To analyze the correlation between immunoglobulin M (IgM) against viral capsid antigen (VCA) of Epstein-Barr virus (EBV) and T helper 1 and 2 (Th1/Th2) immunocytokines (ICKs) in children with...
5.
Wei G, Zhang Y, Zhao H, Wang Y, Liu Y, Liang B, et al.
Cancer Immunol Res
. 2021 Jul;
9(9):1061-1070.
PMID: 34290048
Chimeric antigen receptor (CAR) T-cell therapies that target either CD19 or CD22 alone have potent antilymphoma effects. However, antigen escape-mediated relapse often occurs. CAR T cells targeting both CD19 and...
6.
Zhu F, Wei G, Liu Y, Zhou H, Wu W, Yang L, et al.
Cell Transplant
. 2021 Jun;
30:9636897211025503.
PMID: 34144648
Chimeric antigen receptor T cells (CAR-Ts) constitute a novel therapeutic strategy for relapsed/refractory B-cell malignancies. With the extensive application of CAR-T therapy in clinical settings, CAR-T-associated toxicities have become increasingly...
7.
He D, Huang B, Fu S, Li Y, Ran X, Liu Y, et al.
Int J Mol Sci
. 2018 Aug;
19(8).
PMID: 30065205
Parkinson's disease (PD), a frequent degenerative disease in the elderly, is characterized by dopaminergic neurodegeneration in the substantia nigra pars compacta (SNpc). Neuroinflammation caused by over-activated microglia plays a crucial...